Kevin Pong

Company: Anima Biotech

Job title: Chief Business Officer

Seminars:

Translation Regulation of KRAS mRNA as a Unique Mutation Agnostic Approach 4:00 pm

Cancer biology: KRAS mRNA dysregulation as a driver for tumorigenesis Discovery platform: Screening for small molecules modulating mutant KRAS mRNA translation Anima’s KRAS mRNA translation modulators target the increased translation efficiency of mutant KRAS in tumor cellsRead more

day: Day Two Track E